Premium
A mutation in SCARB2 is a modifier in gaucher disease
Author(s) -
Velayati Arash,
DePaolo John,
Gupta Nidhi,
Choi Jae H.,
Moaven Nima,
Westbroek Wendy,
GokerAlpan Ozlem,
Goldin Ehud,
Stubblefield Barbara K.,
Kolodny Edwin,
Tayebi Nahid,
Sidransky Ellen
Publication year - 2011
Publication title -
human mutation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.981
H-Index - 162
eISSN - 1098-1004
pISSN - 1059-7794
DOI - 10.1002/humu.21566
Subject(s) - glucocerebrosidase , progressive myoclonus epilepsy , myoclonic epilepsy , epilepsy , biology , mutation , limp , genetics , phenotype , medicine , bioinformatics , gene , neuroscience
Lysosomal integral membrane protein type 2 (LIMP‐2) is responsible for proper sorting and lysosomal targeting of glucocerebrosidase, the enzyme deficient in Gaucher disease (GD). Mutations in the gene for LIMP‐2, SCARB2 , are implicated in inherited forms of myoclonic epilepsy, and myoclonic epilepsy is part of the phenotypic spectrum associated with GD. We investigated whether SCARB2 mutations impact the Gaucher phenotype focusing on patients with myoclonic epilepsy, including a pair of siblings with GD who were discordant for myoclonic seizures. Sequencing of SCARB2 genomic and cDNA identified a heterozygous, maternally inherited novel mutation, c.1412A>G (p.Glu471Gly), in the brother with GD and myoclonic epilepsy, absent from his sibling and controls. Glucocerebrosidase activity, Western blots, real‐time PCR, and immunofluorescence studies demonstrated markedly decreased LIMP‐2 and glucocerebrosidase in cells from the sibling with (p.Glu471Gly) LIMP‐2, and diminished glucocerebrosidase in lysosomes. The cells secreted highly glycosylated enzyme and showed mistrafficking of glucocerebrosidase. Sequencing of SCARB2 in 13 other subjects with GD and myoclonic epilepsy and 40 controls failed to identify additional mutations. The study provides further evidence for the association of LIMP‐2 and myoclonic epilepsy, explains the drastically different phenotypes encountered in the siblings, and demonstrates that LIMP‐2 can serve as a modifier in GD. Hum Mutat 32:1232–1238, 2011. ©2011 Wiley Periodicals, Inc.